Predictors of post-electroconvulsive therapy delirium: a prospective randomized study from an Indian tertiary care centre.

Nord J PsychiatryAug 12, 2026 (epub)
Clinical ResearchAnesthesiologyPsychiatry

Sonali Dagar, Vinod Kumar Daria, Usha Daria et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial investigated predictors of early post-electroconvulsive therapy (ECT) delirium in 90 adult patients. The study found that 72.2% experienced delirium at 15 minutes post-ECT, with longer seizure duration significantly increasing the odds of delirium (adjusted OR = 1.09). Thiopental and etomidate were associated with lower odds of delirium compared to propofol.

Key findings

  • 72.2% of patients experienced delirium at 15 minutes post-ECT.
  • 83.1% of those with delirium at 15 minutes recovered by 30 minutes.
  • Longer seizure duration was associated with increased odds of delirium (adjusted OR = 1.09).
  • Thiopental and etomidate had lower adjusted odds of delirium compared to propofol.

Why it matters

Understanding the predictors of post-ECT delirium can help clinicians manage and mitigate this common adverse effect, improving patient recovery and overall treatment outcomes.

Source

Published in Nord J Psychiatry. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Anesthesiology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.